

FibroScan®
…to assess extent of liver scarring (fibrosis)
Assessment
…of fatty liver disease stage and differentiation between simple steatosis and NASH
Advice
…for the management of NAFLD
Assessment
…for cardiac disease due to fatty liver
Access
…to drug and lifestyle trials for new NASH treatments
Screening
…for HBV and HCV infections
FibroScan®
…screening for liver disease
Preparation
…for drug treatment for liver disease
Monitoring
…during and post drug treatment
As Professor of Hepatology and Gastroenterology at Trinity College Dublin, Prof Norris has initiated, participated in, and provided leadership to several research programmes in hepatology and aligned speciality interests. Prof Norris has been national principle investigator for several international clinical trials in hepatitis C. Prof Norris is currently running a research programme, funded by the Health Research Board Ireland, based at the Clinical Research Facility, St James’s Hospital which is investigated the impact of the hepatitis C virus on neurocognitive function. Prof Norris is additionally leading a research programme in NAFLD, which is exploring inflammatory signals in patients with fatty liver.